LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $943 | -20.8% | 15,743 | -4.7% | 0.00% | -33.3% |
| Q2 2023 | $1,191 | -3.6% | 16,517 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $1,235 | +12.3% | 16,786 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $1,100 | -99.9% | 16,463 | -0.7% | 0.00% | -25.0% |
| Q3 2022 | $1,428,000 | -3.4% | 16,580 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $1,478,000 | -3.4% | 16,566 | +21.8% | 0.00% | +33.3% |
| Q1 2022 | $1,530,000 | -27.2% | 13,605 | +0.0% | 0.00% | -25.0% |
| Q4 2021 | $2,101,000 | +11.9% | 13,600 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $1,878,000 | +223.8% | 13,480 | +204.9% | 0.00% | +300.0% |
| Q2 2021 | $580,000 | -13.8% | 4,421 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $673,000 | -88.6% | 4,416 | -92.6% | 0.00% | -92.9% |
| Q4 2020 | $5,895,000 | +5.1% | 59,281 | +0.7% | 0.01% | -6.7% |
| Q3 2020 | $5,609,000 | -17.1% | 58,842 | -2.7% | 0.02% | -25.0% |
| Q2 2020 | $6,766,000 | -15.1% | 60,494 | -44.8% | 0.02% | -31.0% |
| Q1 2020 | $7,972,000 | -85.5% | 109,617 | -79.3% | 0.03% | -81.5% |
| Q4 2019 | $55,114,000 | +23.8% | 528,472 | +18.1% | 0.16% | +13.8% |
| Q3 2019 | $44,530,000 | -10.0% | 447,363 | +3.2% | 0.14% | -8.0% |
| Q2 2019 | $49,499,000 | -7.7% | 433,634 | +1.6% | 0.15% | -11.2% |
| Q1 2019 | $53,643,000 | +41.6% | 426,721 | +52.8% | 0.17% | +23.4% |
| Q4 2018 | $37,885,000 | +859.4% | 279,184 | +1840.5% | 0.14% | +1041.7% |
| Q3 2018 | $3,949,000 | +30.3% | 14,387 | -1.6% | 0.01% | +20.0% |
| Q2 2018 | $3,030,000 | +29.1% | 14,626 | +2.9% | 0.01% | +25.0% |
| Q1 2018 | $2,347,000 | +30.8% | 14,213 | +8.5% | 0.01% | +33.3% |
| Q4 2017 | $1,794,000 | +2.6% | 13,098 | +2.0% | 0.01% | 0.0% |
| Q3 2017 | $1,748,000 | +25.7% | 12,840 | +12.0% | 0.01% | 0.0% |
| Q2 2017 | $1,391,000 | +23.2% | 11,460 | +7.4% | 0.01% | +20.0% |
| Q1 2017 | $1,129,000 | +8.7% | 10,670 | +4.3% | 0.01% | 0.0% |
| Q4 2016 | $1,039,000 | +5.1% | 10,230 | +5.6% | 0.01% | 0.0% |
| Q3 2016 | $989,000 | -9.9% | 9,690 | +5.2% | 0.01% | 0.0% |
| Q2 2016 | $1,098,000 | +27.4% | 9,210 | +14.4% | 0.01% | +25.0% |
| Q1 2016 | $862,000 | +2.5% | 8,050 | +3.7% | 0.00% | 0.0% |
| Q4 2015 | $841,000 | +29.2% | 7,760 | +2.1% | 0.00% | +33.3% |
| Q3 2015 | $651,000 | -7.1% | 7,600 | +9.4% | 0.00% | -25.0% |
| Q2 2015 | $701,000 | +36.6% | 6,950 | +4.5% | 0.00% | +33.3% |
| Q1 2015 | $513,000 | +44.9% | 6,650 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $354,000 | +9.3% | 6,650 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $324,000 | -31.5% | 6,900 | -9.2% | 0.00% | -33.3% |
| Q2 2014 | $473,000 | -6.3% | 7,600 | +1.3% | 0.00% | 0.0% |
| Q1 2014 | $505,000 | +29.8% | 7,500 | +1.4% | 0.00% | +50.0% |
| Q4 2013 | $389,000 | – | 7,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |